Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	6-phosphofructo-2-kinase activity	PFKFB1 PFKFB2 PFKFB4	2.86e-07	4	84	3	GO:0003873
GeneOntologyMolecularFunction	fructose-2,6-bisphosphate 2-phosphatase activity	PFKFB1 PFKFB2 PFKFB4	7.14e-07	5	84	3	GO:0004331
GeneOntologyMolecularFunction	phosphofructokinase activity	PFKFB1 PFKFB2 PFKFB4	2.48e-06	7	84	3	GO:0008443
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B HLA-C	5.92e-06	9	84	3	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B HLA-C	5.92e-06	9	84	3	GO:0062061
GeneOntologyMolecularFunction	sugar-phosphatase activity	PFKFB1 PFKFB2 PFKFB4	8.44e-06	10	84	3	GO:0050308
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B HLA-C	8.44e-06	10	84	3	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B HLA-C	8.44e-06	10	84	3	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B HLA-C	8.44e-06	10	84	3	GO:0046977
GeneOntologyMolecularFunction	carbohydrate phosphatase activity	PFKFB1 PFKFB2 PFKFB4	1.16e-05	11	84	3	GO:0019203
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B HLA-C	1.54e-05	12	84	3	GO:0030881
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-B HLA-C	4.68e-05	17	84	3	GO:0046703
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DYNC2H1 DNAH7	5.60e-05	18	84	3	GO:0008569
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-B HLA-C	7.77e-05	20	84	3	GO:0042608
GeneOntologyMolecularFunction	carbohydrate kinase activity	PFKFB1 PFKFB2 PFKFB4	9.04e-05	21	84	3	GO:0019200
GeneOntologyMolecularFunction	MHC protein binding	COL2A1 HLA-A HLA-B HLA-C	1.04e-04	58	84	4	GO:0042287
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	1.04e-04	4	84	2	GO:0005219
GeneOntologyMolecularFunction	phosphatase activity	MTMR14 ACP2 MTM1 ENTPD3 PFKFB1 PFKFB2 PFKFB4	2.07e-04	287	84	7	GO:0016791
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DYNC2H1 DNAH7	2.18e-04	28	84	3	GO:0051959
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	2.59e-04	6	84	2	GO:0048763
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-B HLA-C	3.26e-04	32	84	3	GO:0042288
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DYNC2H1 DNAH7	5.03e-04	37	84	3	GO:0045505
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-B HLA-C	7.32e-04	42	84	3	GO:0071889
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	MTMR14 MTM1	9.38e-04	11	84	2	GO:0052629
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 ABCC1 DYNC2H1 MYO1F HFM1 ACSF2 DNAH7 HSPA4 TOP2A	1.10e-03	614	84	9	GO:0140657
GeneOntologyMolecularFunction	peptide antigen binding	HLA-A HLA-B HLA-C	1.15e-03	49	84	3	GO:0042605
GeneOntologyMolecularFunction	phosphoric ester hydrolase activity	MTMR14 ACP2 MTM1 ENTPD3 PFKFB1 PFKFB2 PFKFB4	1.21e-03	386	84	7	GO:0042578
GeneOntologyMolecularFunction	antigen binding	HLA-A HLA-B HLA-C IGHG1 EP300	1.24e-03	190	84	5	GO:0003823
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	MTMR14 MTM1	1.54e-03	14	84	2	GO:0004438
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 DYNC2H1 MYO1F DNAH7	1.55e-03	118	84	4	GO:0003774
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	MTMR14 MTM1	1.77e-03	15	84	2	GO:0052744
GeneOntologyMolecularFunction	protein kinase A binding	PJA2 AKAP3 RYR2	1.88e-03	58	84	3	GO:0051018
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	MTMR14 MTM1	2.02e-03	16	84	2	GO:0106018
GeneOntologyMolecularFunction	protein kinase A catalytic subunit binding	PJA2 RYR2	2.02e-03	16	84	2	GO:0034236
GeneOntologyMolecularFunction	calcium channel activity	CACNA2D1 PKDREJ RYR2 RYR3	2.15e-03	129	84	4	GO:0005262
GeneOntologyMolecularFunction	calcium-dependent cysteine-type endopeptidase activity	CAPN6 CAPN5	2.28e-03	17	84	2	GO:0004198
GeneOntologyMolecularFunction	intracellularly gated calcium channel activity	RYR2 RYR3	2.56e-03	18	84	2	GO:0015278
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 DYNC2H1 DNAH7	3.21e-03	70	84	3	GO:0003777
GeneOntologyMolecularFunction	calcium ion transmembrane transporter activity	CACNA2D1 PKDREJ RYR2 RYR3	3.80e-03	151	84	4	GO:0015085
GeneOntologyMolecularFunction	protein-folding chaperone binding	HLA-A HLA-B HLA-C CDK1	4.76e-03	161	84	4	GO:0051087
GeneOntologyMolecularFunction	protein kinase A regulatory subunit binding	PJA2 RYR2	4.93e-03	25	84	2	GO:0034237
GeneOntologyMolecularFunction	cysteine-type endopeptidase activity	CAPN6 CAPN5 USP48	5.72e-03	86	84	3	GO:0004197
GeneOntologyMolecularFunction	phosphatidylinositol bisphosphate phosphatase activity	MTMR14 MTM1	5.73e-03	27	84	2	GO:0034593
GeneOntologyMolecularFunction	hydrolase activity, acting on ester bonds	FASN MTMR14 ACP2 MTM1 ENTPD3 PFKFB1 PFKFB2 PFKFB4 DAGLA	6.76e-03	807	84	9	GO:0016788
GeneOntologyMolecularFunction	phosphatidylinositol phosphate phosphatase activity	MTMR14 MTM1	7.05e-03	30	84	2	GO:0052866
GeneOntologyMolecularFunction	ligand-gated calcium channel activity	RYR2 RYR3	7.51e-03	31	84	2	GO:0099604
GeneOntologyMolecularFunction	intracellularly ligand-gated monoatomic ion channel activity	RYR2 RYR3	8.48e-03	33	84	2	GO:0005217
GeneOntologyBiologicalProcess	fructose 2,6-bisphosphate metabolic process	PFKFB1 PFKFB2 PFKFB4	1.29e-06	6	84	3	GO:0006003
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-B HLA-C	3.60e-06	8	84	3	GO:0002485
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-B HLA-C	3.51e-05	16	84	3	GO:0002486
GeneOntologyBiologicalProcess	fructose metabolic process	PFKFB1 PFKFB2 PFKFB4	3.51e-05	16	84	3	GO:0006000
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-B HLA-C	4.25e-05	17	84	3	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C	4.25e-05	17	84	3	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-B HLA-C	5.09e-05	18	84	3	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C	5.09e-05	18	84	3	GO:0042590
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-C	1.09e-04	23	84	3	GO:0019885
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-B HLA-C	1.40e-04	25	84	3	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-B HLA-C	1.40e-04	25	84	3	GO:0002475
GeneOntologyBiologicalProcess	carbohydrate phosphorylation	PFKFB1 PFKFB2 PFKFB4	1.40e-04	25	84	3	GO:0046835
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B HLA-C VPS13B	5.55e-07	17	84	4	GO:0033106
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B HLA-C	2.17e-06	7	84	3	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B HLA-C	7.36e-06	10	84	3	GO:0042612
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B HLA-C	2.21e-05	14	84	3	GO:0042824
GeneOntologyCellularComponent	Golgi medial cisterna	HLA-A HLA-B HLA-C	1.05e-04	23	84	3	GO:0005797
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B HLA-C	1.52e-04	26	84	3	GO:0042611
GeneOntologyCellularComponent	collagen type XI trimer	COL2A1 COL5A2	1.58e-04	5	84	2	GO:0005592
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-B HLA-C	3.73e-04	35	84	3	GO:0098553
GeneOntologyCellularComponent	cis-Golgi network	HLA-A HLA-B HLA-C VPS13B	3.83e-04	85	84	4	GO:0005801
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-B HLA-C	6.42e-04	42	84	3	GO:0070971
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH7	7.03e-04	10	84	2	GO:0036156
GeneOntologyCellularComponent	supramolecular fiber	COL2A1 COL5A2 EML5 KCNE1 DYNC2H1 MTM1 CAPN6 MYO1F EML2 CDK1 DNAH7 RYR2 RYR3	8.16e-04	1179	84	13	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	COL2A1 COL5A2 EML5 KCNE1 DYNC2H1 MTM1 CAPN6 MYO1F EML2 CDK1 DNAH7 RYR2 RYR3	8.69e-04	1187	84	13	GO:0099081
GeneOntologyCellularComponent	lumenal side of membrane	HLA-A HLA-B HLA-C	9.50e-04	48	84	3	GO:0098576
GeneOntologyCellularComponent	fibrillar collagen trimer	COL2A1 COL5A2	1.03e-03	12	84	2	GO:0005583
GeneOntologyCellularComponent	banded collagen fibril	COL2A1 COL5A2	1.03e-03	12	84	2	GO:0098643
GeneOntologyCellularComponent	recycling endosome membrane	HLA-A HLA-B HLA-C VPS13B	1.08e-03	112	84	4	GO:0055038
GeneOntologyCellularComponent	postsynaptic membrane	IL1RAPL1 CACNA2D1 ADGRB3 NECTIN3 USP48 DAGLA NRP2	1.22e-03	405	84	7	GO:0045211
GeneOntologyCellularComponent	dynein complex	DNHD1 DYNC2H1 DNAH7	1.34e-03	54	84	3	GO:0030286
GeneOntologyCellularComponent	early endosome membrane	HLA-A HLA-B HLA-C DAGLA VPS13B	1.65e-03	212	84	5	GO:0031901
GeneOntologyCellularComponent	Golgi cisterna	HLA-A HLA-B HLA-C CSGALNACT1	2.15e-03	135	84	4	GO:0031985
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	HLA-A HLA-B HLA-C	2.19e-03	64	84	3	GO:0012507
GeneOntologyCellularComponent	synaptic membrane	IL1RAPL1 CACNA2D1 ADGRB3 NCAM2 NECTIN3 USP48 DAGLA NRP2	2.37e-03	583	84	8	GO:0097060
GeneOntologyCellularComponent	9+2 motile cilium	DNHD1 GK2 DYNC2H1 AKAP3 DNAH7	2.73e-03	238	84	5	GO:0097729
GeneOntologyCellularComponent	cilium	TNPO1 DNHD1 PJA2 GK2 DYNC2H1 GPR37L1 AKAP3 RAB15 USP48 DNAH7	3.17e-03	898	84	10	GO:0005929
GeneOntologyCellularComponent	calcium channel complex	CACNA2D1 RYR2 RYR3	3.18e-03	73	84	3	GO:0034704
GeneOntologyCellularComponent	complex of collagen trimers	COL2A1 COL5A2	3.19e-03	21	84	2	GO:0098644
GeneOntologyCellularComponent	postsynaptic density membrane	IL1RAPL1 ADGRB3 NECTIN3 DAGLA	3.71e-03	157	84	4	GO:0098839
GeneOntologyCellularComponent	microtubule associated complex	DNHD1 DYNC2H1 EML2 DNAH7	4.06e-03	161	84	4	GO:0005875
GeneOntologyCellularComponent	axonemal dynein complex	DNHD1 DNAH7	4.51e-03	25	84	2	GO:0005858
GeneOntologyCellularComponent	I band	KCNE1 MTM1 RYR2 RYR3	4.52e-03	166	84	4	GO:0031674
GeneOntologyCellularComponent	phagocytic vesicle membrane	HLA-A HLA-B HLA-C	4.56e-03	83	84	3	GO:0030670
GeneOntologyCellularComponent	Golgi stack	HLA-A HLA-B HLA-C CSGALNACT1	5.02e-03	171	84	4	GO:0005795
GeneOntologyCellularComponent	sarcoplasmic reticulum	CACNA2D1 RYR2 RYR3	5.37e-03	88	84	3	GO:0016529
MousePheno	spinal cord inflammation	HLA-A HLA-B HLA-C	6.33e-06	8	69	3	MP:0030987
Domain	6Pfruct_kin	PFKFB1 PFKFB2 PFKFB4	3.50e-07	4	84	3	IPR003094
Domain	6Phosfructo_kin	PFKFB1 PFKFB2 PFKFB4	3.50e-07	4	84	3	IPR013079
Domain	6PF2K	PFKFB1 PFKFB2 PFKFB4	3.50e-07	4	84	3	PF01591
Domain	MHC_I_a_C	HLA-A HLA-B HLA-C	1.74e-06	6	84	3	IPR010579
Domain	MHC_I_C	HLA-A HLA-B HLA-C	1.74e-06	6	84	3	PF06623
Domain	His_PPase_superfam	ACP2 PFKFB1 PFKFB2 PFKFB4	1.75e-06	20	84	4	IPR029033
Domain	-	ACP2 PFKFB1 PFKFB2 PFKFB4	1.75e-06	20	84	4	3.40.50.1240
Domain	PG/BPGM_mutase_AS	PFKFB1 PFKFB2 PFKFB4	7.23e-06	9	84	3	IPR001345
Domain	PGAM	PFKFB1 PFKFB2 PFKFB4	1.03e-05	10	84	3	SM00855
Domain	PG_MUTASE	PFKFB1 PFKFB2 PFKFB4	1.03e-05	10	84	3	PS00175
Domain	His_Phos_1	PFKFB1 PFKFB2 PFKFB4	1.88e-05	12	84	3	PF00300
Domain	His_Pase_superF_clade-1	PFKFB1 PFKFB2 PFKFB4	1.88e-05	12	84	3	IPR013078
Domain	C2_Calpain	CAPN6 CAPN5	2.00e-05	2	84	2	IPR033884
Domain	Dynein_HC_stalk	DNHD1 DYNC2H1 DNAH7	3.08e-05	14	84	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DYNC2H1 DNAH7	3.08e-05	14	84	3	IPR013602
Domain	DHC_N2	DNHD1 DYNC2H1 DNAH7	3.08e-05	14	84	3	PF08393
Domain	MT	DNHD1 DYNC2H1 DNAH7	3.08e-05	14	84	3	PF12777
Domain	DHC_fam	DNHD1 DYNC2H1 DNAH7	3.84e-05	15	84	3	IPR026983
Domain	Dynein_heavy_dom	DNHD1 DYNC2H1 DNAH7	3.84e-05	15	84	3	IPR004273
Domain	Dynein_heavy	DNHD1 DYNC2H1 DNAH7	3.84e-05	15	84	3	PF03028
Domain	Ryanrecept_TM4-6	RYR2 RYR3	5.98e-05	3	84	2	IPR009460
Domain	RyR	RYR2 RYR3	5.98e-05	3	84	2	PF02026
Domain	Ryanodine_rcpt	RYR2 RYR3	5.98e-05	3	84	2	IPR003032
Domain	RR_TM4-6	RYR2 RYR3	5.98e-05	3	84	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	5.98e-05	3	84	2	IPR013333
Domain	C1-set	HLA-A HLA-B HLA-C IGHG1	1.01e-04	54	84	4	PF07654
Domain	MHC_I	HLA-A HLA-B HLA-C	1.10e-04	21	84	3	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B HLA-C	1.10e-04	21	84	3	IPR001039
Domain	IGc1	HLA-A HLA-B HLA-C IGHG1	1.17e-04	56	84	4	SM00407
Domain	Ig_C1-set	HLA-A HLA-B HLA-C IGHG1	1.34e-04	58	84	4	IPR003597
Domain	Ig/MHC_CS	HLA-A HLA-B HLA-C IGHG1	1.34e-04	58	84	4	IPR003006
Domain	IG_MHC	HLA-A HLA-B HLA-C IGHG1	1.53e-04	60	84	4	PS00290
Domain	-	HLA-A HLA-B HLA-C	1.66e-04	24	84	3	3.30.500.10
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B HLA-C	1.66e-04	24	84	3	IPR011161
Domain	RIH_assoc	RYR2 RYR3	2.96e-04	6	84	2	PF08454
Domain	RIH_assoc-dom	RYR2 RYR3	2.96e-04	6	84	2	IPR013662
Domain	RIH_dom	RYR2 RYR3	2.96e-04	6	84	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	2.96e-04	6	84	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	2.96e-04	6	84	2	IPR015925
Domain	-	RYR2 RYR3	2.96e-04	6	84	2	1.25.10.30
Domain	HELP	EML5 EML2	2.96e-04	6	84	2	PF03451
Domain	RYDR_ITPR	RYR2 RYR3	2.96e-04	6	84	2	PF01365
Domain	HELP	EML5 EML2	2.96e-04	6	84	2	IPR005108
Domain	Ins145_P3_rec	RYR2 RYR3	2.96e-04	6	84	2	PF08709
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B HLA-C	6.61e-04	38	84	3	IPR011162
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	PS50919
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	PF02815
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	SM00472
Domain	MIR_motif	RYR2 RYR3	8.79e-04	10	84	2	IPR016093
Domain	Fib_collagen_C	COL2A1 COL5A2	1.07e-03	11	84	2	IPR000885
Domain	COLFI	COL2A1 COL5A2	1.07e-03	11	84	2	PF01410
Domain	NC1_FIB	COL2A1 COL5A2	1.07e-03	11	84	2	PS51461
Domain	Fib_collagen_C	COL2A1 COL5A2	1.07e-03	11	84	2	PD002078
Domain	COLFI	COL2A1 COL5A2	1.07e-03	11	84	2	SM00038
Domain	Calpain_III	CAPN6 CAPN5	1.28e-03	12	84	2	IPR022683
Domain	calpain_III	CAPN6 CAPN5	1.28e-03	12	84	2	SM00720
Domain	C2_III	CAPN6 CAPN5	1.28e-03	12	84	2	IPR033883
Domain	Quinoprot_gluc/sorb_DH	EML5 EML2	1.28e-03	12	84	2	IPR011041
Domain	Calpain_domain_III	CAPN6 CAPN5	1.51e-03	13	84	2	IPR022682
Domain	Calpain_III	CAPN6 CAPN5	1.51e-03	13	84	2	PF01067
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DNAH7	1.76e-03	14	84	2	IPR024317
Domain	Calpain_cysteine_protease	CAPN6 CAPN5	1.76e-03	14	84	2	IPR022684
Domain	AAA_8	DYNC2H1 DNAH7	1.76e-03	14	84	2	PF12780
Domain	-	DNHD1 ABCC1 DYNC2H1 MYO1F RAB15 HFM1 PFKFB1 PFKFB2 PFKFB4 DNAH7	1.86e-03	746	84	10	3.40.50.300
Domain	CysPc	CAPN6 CAPN5	2.02e-03	15	84	2	SM00230
Domain	Peptidase_C2_calpain_cat	CAPN6 CAPN5	2.02e-03	15	84	2	IPR001300
Domain	Peptidase_C2	CAPN6 CAPN5	2.02e-03	15	84	2	PF00648
Domain	CALPAIN_CAT	CAPN6 CAPN5	2.02e-03	15	84	2	PS50203
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	1.77e-06	6	64	3	M47468
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	3.08e-06	7	64	3	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	3.08e-06	7	64	3	M47530
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C	7.35e-06	9	64	3	MM14527
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-C	1.43e-05	11	64	3	M525
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PFKFB1 PFKFB2 PFKFB4	1.91e-05	12	64	3	M27950
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-C	1.91e-05	12	64	3	M47529
Pathway	WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING	DAGLA RYR2 RYR3	2.47e-05	13	64	3	M39589
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-B HLA-C	6.94e-05	18	64	3	MM14525
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-B HLA-C	9.63e-05	20	64	3	MM1374
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C	1.91e-04	25	64	3	MM15713
Pathway	BIOCARTA_NKCELLS_PATHWAY	HLA-A HLA-B HLA-C	1.91e-04	25	64	3	MM1465
Pathway	WP_UROTENSINIIMEDIATED_SIGNALING	COL2A1 CDK1 MAPK8 EP300	2.68e-04	69	64	4	M48052
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-C	3.00e-04	29	64	3	M1062
Pathway	PID_RETINOIC_ACID_PATHWAY	CDK1 MAPK8 EP300	3.32e-04	30	64	3	M207
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	HLA-A HLA-B HLA-C NCAM2 NECTIN3	3.38e-04	133	64	5	M16476
Pathway	KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM	PFKFB1 PFKFB2 PFKFB4	4.83e-04	34	64	3	M15898
Pathway	REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES	ABCC1 EP300	5.58e-04	8	64	2	M48022
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-C	6.21e-04	37	64	3	M18615
Pathway	KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	HLA-A HLA-B HLA-C HSPA4	6.77e-04	88	64	4	M16004
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-A HLA-B HLA-C	8.41e-04	41	64	3	M13519
Pubmed	Filling the gaps - the generation of full genomic sequences for 15 common and well-documented HLA class I alleles using next-generation sequencing technology.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	23246585
Pubmed	The detailed distribution of HLA-A, B, C antigens in normal human organs.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	6591601
Pubmed	Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11390610
Pubmed	HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19694795
Pubmed	[Association of gene HLA-class I with leukemia].	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	16129034
Pubmed	Persistence of hepatitis C virus in a white population: associations with human leukocyte antigen class 1.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15301865
Pubmed	[Studies of the relationship of HLA polymorphisms and the infection of H. pylori in the population of Linqu in Shandong Province].	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15662734
Pubmed	Impact of HLA-A,B,C allele mismatches on outcome after unrelated blood stem cell transplantation in whites.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15480178
Pubmed	HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11053636
Pubmed	HLA-A11:01:01:01, HLA-C12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	33968060
Pubmed	The role of HLA class I gene variation in autoimmune diabetes.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17491685
Pubmed	Association of human leukocyte antigen class I antigens in Iranian patients with pemphigus vulgaris.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	23330836
Pubmed	HLA-A02:01:01/-B35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	25495410
Pubmed	Transcription of preintegrated HIV-1 cDNA modulates cell surface expression of major histocompatibility complex class I via Nef.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	21209113
Pubmed	Genetic epidemiology of glioblastoma multiforme: confirmatory and new findings from analyses of human leukocyte antigen alleles and motifs.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19774073
Pubmed	Serological HLA class I alleles in Senegalese blood donors detected HBs Ag positive.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11064107
Pubmed	HLA alleles associated with slow progression to AIDS truly prefer to present HIV-1 p24.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17878955
Pubmed	HIV-1 accessory proteins: Nef.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	24158818
Pubmed	Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18684953
Pubmed	Allelic distribution of HLA class I genes in the Tibetan ethnic population of China.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17117954
Pubmed	HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17909631
Pubmed	Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	10715516
Pubmed	Four new HLA class I alleles in Cauacasoids.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15982258
Pubmed	The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	21482733
Pubmed	Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15009803
Pubmed	Polymorphism of HLA class I genes in Meizhou Han population of Guangdong, China.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17373939
Pubmed	HLA-A*24020102L in the UK blood donor population.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15140038
Pubmed	[Association of HLA class I and leukemia in mestizo patients of the state of Zulia, Venezuela].	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	14727382
Pubmed	HLA Class I Polymorphisms Influencing Both Peptide Binding and KIR Interactions Are Associated with Remission among Children with Atopic Dermatitis: A Longitudinal Study.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	33863792
Pubmed	Host genetics and HIV-1 viral load set-point in African-Americans.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19276793
Pubmed	Prospective analysis of HLA classes I and II antigen frequency in patients with Peyronie's disease.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	14501786
Pubmed	Human leukocyte antigens as genetic markers in Greek patients with sporadic pancreatic cancer.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15211110
Pubmed	Additive contribution of HLA class I alleles in the immune control of HIV-1 infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20660184
Pubmed	HLA class I polymorphism in the Cuban population.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18082573
Pubmed	HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A2612-B4407 haplotype.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	16451198
Pubmed	Molecular diversity of HLA-A, -B and -C alleles in a North Indian population as determined by PCR-SSOP.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17504510
Pubmed	HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	22826228
Pubmed	HLA-A, HLA-B and HLA-C polymorphism in the Slovak population.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	10954160
Pubmed	Association between HLA inheritance and asthma medication use in HIV positive children.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20613458
Pubmed	NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I molecules.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	24554773
Pubmed	Association of HLA class I alleles with psoriasis vulgaris in southeastern Chinese Hans.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	14527733
Pubmed	Association of human leukocyte antigen and esophageal cancer in North of Iran.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20334121
Pubmed	The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	9104816
Pubmed	HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20504258
Pubmed	Distributions of HLA class I alleles and haplotypes in Northern Han Chinese.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	16185325
Pubmed	Locus-specific constitutive and cytokine-induced HLA class I gene expression.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	12574356
Pubmed	Hla-Cw7 allele as predictor of favorable therapeutic response to interferon-alpha in patients with chronic hepatitis C.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18074415
Pubmed	[Haplotype and linkage analysis of HLA-I classical genes in Chinese Han population].	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17956696
Pubmed	Orientation of loci within the human major histocompatibility complex by chromosomal in situ hybridization.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	6585830
Pubmed	Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18097038
Pubmed	Human leukocyte antigen class I alleles and cervical neoplasia: no heterozygote advantage.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11927505
Pubmed	Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19663693
Pubmed	Human Leukocyte Antigen Class I Genes Associated With Stevens-Johnson Syndrome and Severe Ocular Complications Following Use of Cold Medicine in a Brazilian Population.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	28278336
Pubmed	Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	16331510
Pubmed	Allelic diversity and haplotype structure of HLA loci in the Chinese Han population living in the Guanzhong region of the Shaanxi province.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20219611
Pubmed	HIV and human leukocyte antigen association--the Indian scenario.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15534563
Pubmed	HLA B*44: protective effects in MS susceptibility and MRI outcome measures.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20713950
Pubmed	Polymorphism of HLA class I genes in the Brazilian population from the Northeastern State of Pernambuco corroborates anthropological evidence of its origin.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15245377
Pubmed	Human leukocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15245373
Pubmed	Transmission of HIV-1 and HLA-B allele-sharing within serodiscordant heterosexual Zambian couples.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15220037
Pubmed	Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18580606
Pubmed	The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11120862
Pubmed	Immune selection in vitro reveals human immunodeficiency virus type 1 Nef sequence motifs important for its immune evasion function in vivo.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	22553319
Pubmed	HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18434400
Pubmed	Effects of human leukocyte antigen class I genetic parameters on clinical outcomes and survival after initiation of highly active antiretroviral therapy.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17471440
Pubmed	Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	8617941
Pubmed	HLA diversity among Nadars, a primitive Dravidian caste of South India.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	14617038
Pubmed	Impact of donor mismatches at individual HLA-A, -B, -C, -DR, and -DQ loci on the development of HLA-specific antibodies in patients listed for repeat renal transplantation.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	24717292
Pubmed	CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	20065064
Pubmed	Distinguishing functional polymorphism from random variation in the sequences of >10,000 HLA-A, -B and -C alleles.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	28650991
Pubmed	Novel HLA Class I Alleles Associated with Indian Leprosy Patients.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	12975536
Pubmed	Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17207712
Pubmed	Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19232441
Pubmed	Association of HLA class I alleles with keloids in Chinese Han individuals.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19932885
Pubmed	HLA class I polymorphism, as characterised by PCR-SSOP, in a Brazilian exogamic population.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11144289
Pubmed	[Immunogenetic HLA markers of chronic viral hepatitis].	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15807454
Pubmed	Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11543903
Pubmed	High frequency of transmitted HIV-1 Gag HLA class I-driven immune escape variants but minimal immune selection over the first year of clade C infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	25781986
Pubmed	HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	18521626
Pubmed	Association of class I HLA antigens with the clinical manifestations of Turkish patients with Behçet's disease.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	12372094
Pubmed	Evolutionary relationship between immunoglobulins and transplantation antigens.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	1055432
Pubmed	Unusual HLA-B alleles in two tribes of Brazilian Indians.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	1317015
Pubmed	Association of HLA class I alleles with aloplecia areata in Chinese Hans.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	16185849
Pubmed	Behçet disease, new insights in disease associations and manifestations: a next-generation sequencing study.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	33421092
Pubmed	Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	21352198
Pubmed	HLA class I diversity in Kolla Amerindians.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	11182228
Pubmed	HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	36605212
Pubmed	Strong association between HLA-A*0206 and Stevens-Johnson syndrome in the Japanese.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17258541
Pubmed	HLA associations in leprosy patients from Mumbai, India.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	15072129
Pubmed	HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19019964
Pubmed	HLA class I polymorphism in Mongolian and Hui ethnic groups from Northern China.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	17462512
Pubmed	Polymorphic insertions in 5 Alu loci within the major histocompatibility complex class I region and their linkage disequilibria with HLA alleles in four distinct populations in mainland China.	HLA-A HLA-B HLA-C	1.36e-08	3	84	3	19054371
Pubmed	Vitamin A-enhanced cleft palate susceptibility gene maps between C4 and B144 within the H-2 complex.	HLA-A HLA-B HLA-C ACP2	3.11e-08	14	84	4	8456115
Pubmed	Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	12594841
Pubmed	Nef-mediated down-regulation of CD4 and HLA class I in HIV-1 subtype C infection: association with disease progression and influence of immune pressure.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	25193656
Pubmed	Evidence for novel DRB1*15 allele association among clinically definite multiple sclerosis patients from Mumbai, India.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	12651075
Pubmed	Expression of human placental-type 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase in various cells and cell lines.	PFKFB1 PFKFB2 PFKFB4	5.43e-08	4	84	3	9464277
Pubmed	High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	24046013
Pubmed	Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	11861287
Pubmed	Receptor-mediated ER export of human MHC class I molecules is regulated by the C-terminal single amino acid.	HLA-A HLA-B HLA-C	5.43e-08	4	84	3	20946353
Interaction	CD8A interactions	HLA-A HLA-B HLA-C CDK1	3.91e-06	26	84	4	int:CD8A
Interaction	LILRB1 interactions	HLA-A HLA-B HLA-C	8.21e-06	10	84	3	int:LILRB1
Interaction	LILRB2 interactions	HLA-A HLA-B HLA-C	8.21e-06	10	84	3	int:LILRB2
Interaction	TLR9 interactions	MCMBP HLA-C GUCY1B1 UGGT1 HSPA4	1.53e-05	75	84	5	int:TLR9
GeneFamily	6-phosphofructo-2-kinases/fructose-2,6-biphosphatases	PFKFB1 PFKFB2 PFKFB4	1.85e-07	4	66	3	1077
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	3.93e-05	3	66	2	287
GeneFamily	C1-set domain containing	HLA-A HLA-B HLA-C	4.82e-04	42	66	3	591
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B HLA-C	5.53e-04	44	66	3	588
GeneFamily	C2 domain containing\|Calpains	CAPN6 CAPN5	1.34e-03	15	66	2	975
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR14 MTM1	1.34e-03	15	66	2	903
Coexpression	BENPORATH_NANOG_TARGETS	TNPO1 IL1RAPL1 CACNA2D1 TCF20 MTM1 RAB15 CDK1 MAPK8 PRPF39 HSPA4 TOP2A RYR3 SON CDC7	2.90e-06	988	84	14	M6616
Coexpression	MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	CACNA2D1 ACP2 UGGT1 CAPRIN2 EML2 NCAM2	3.92e-06	130	84	6	M6590
Coexpression	TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING	FASN HLA-A HLA-B HLA-C	1.21e-05	44	84	4	MM3775
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-B HLA-C	1.73e-05	16	84	3	MM3766
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	HLA-A HLA-B HLA-C SON	2.36e-05	52	84	4	MM3808
Coexpression	NUYTTEN_EZH2_TARGETS_UP	IL1RAPL1 RTP3 GCNT3 TCF20 HLA-B RCAN1 HLA-C DHRS9 CAPRIN2 PFKFB2 NECTIN3 PFKFB4 DAGLA	2.40e-05	1033	84	13	M4196
Coexpression	CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	ABCC1 FANCI CDK1 SLC7A7 TOP2A CDC7	2.44e-05	179	84	6	M3268
Coexpression	KANG_DOXORUBICIN_RESISTANCE_UP	ABCC1 FANCI CDK1 TOP2A	2.75e-05	54	84	4	M1037
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-B HLA-C	2.96e-05	19	84	3	MM797
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-C	2.96e-05	19	84	3	MM862
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-B HLA-C	3.48e-05	20	84	3	MM3682
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-B HLA-C	4.05e-05	21	84	3	MM651
Coexpression	POOLA_INVASIVE_BREAST_CANCER_UP	PRUNE2 COL5A2 IGHG1 FANCI CDK1 SLC7A7 TOP2A	4.31e-05	292	84	7	M5369
Coexpression	ONKEN_UVEAL_MELANOMA_UP	TNPO1 ABCC1 FASN HLA-B RCAN1 SLC20A1 CAPRIN2 CDK1 USP48 SLC38A6 VPS13B	4.36e-05	790	84	11	M12490
Coexpression	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN	COL5A2 H1-10 MTMR14 CAPN6 PRPF39 PKDREJ	4.41e-05	199	84	6	M3907
Coexpression	GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP	TNPO1 SLC20A1 EML2 PFKFB1 MAPK8 DNAH7	4.54e-05	200	84	6	M5165
Coexpression	GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP	PLA2R1 SLC20A1 MAPK8 DNAH7 HSPA4 NRP2	4.54e-05	200	84	6	M5247
Coexpression	GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN	TTLL12 HLA-B HLA-C FANCI TOP2A CDC7	4.54e-05	200	84	6	M7143
Coexpression	TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING	HLA-A HLA-B HLA-C CDK1 TOP2A SON	4.93e-05	203	84	6	MM3795
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING	HLA-A HLA-B HLA-C NECTIN3 SON	5.00e-05	124	84	5	MM3726
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	HLA-A HLA-B HLA-C	6.12e-05	24	84	3	MM3773
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-A HLA-B HLA-C	6.94e-05	25	84	3	MM672
Coexpression	MULLIGHAN_NPM1_SIGNATURE_3_UP	CACNA2D1 ACP2 UGGT1 CAPRIN2 EML2 NCAM2 SON	1.02e-04	335	84	7	M10277
Coexpression	GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS	PRUNE2 TSNAXIP1 KCNE1 DYNC2H1 CAPSL DHRS9 DNAH7 NRP2	1.13e-04	459	84	8	M39136
Coexpression	KIM_LRRC3B_TARGETS	HLA-A HLA-B HLA-C	1.21e-04	30	84	3	M17363
Coexpression	PUJANA_ATM_PCC_NETWORK	ABCC1 TCF20 KCNE1 FANCI GPR37L1 CDK1 PFKFB2 PFKFB4 MAPK8 HSPA4 EP300 TOP2A NRP2 CDC7	1.30e-04	1394	84	14	M9585
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING	HLA-A HLA-B HLA-C	1.34e-04	31	84	3	MM3729
Coexpression	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	HLA-A HLA-B	1.51e-04	6	84	2	M7182
Coexpression	DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS	HLA-A HLA-B HLA-C MYO1F	1.56e-04	84	84	4	M39287
Coexpression	TABULA_MURIS_SENIS_TONGUE_BASAL_CELL_OF_EPIDERMIS_AGEING	HLA-A HLA-B HLA-C CDK1 TOP2A	1.57e-04	158	84	5	MM3851
Coexpression	GAVIN_FOXP3_TARGETS_CLUSTER_P3	IGHG1 RIN2 MTM1 MYO1F USP48	1.72e-04	161	84	5	M1733
Coexpression	PAL_PRMT5_TARGETS_DN	HLA-A HLA-B HLA-C	1.93e-04	35	84	3	MM674
Coexpression	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	COL2A1 CDK1 TOP2A NRP2	1.95e-04	89	84	4	M2761
Coexpression	COATES_MACROPHAGE_M1_VS_M2_DN	HLA-A HLA-B HLA-C MYO1F	2.03e-04	90	84	4	MM750
Coexpression	TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-B HLA-C GUCY1B1	2.21e-04	92	84	4	MM3748
Coexpression	HAN_SATB1_TARGETS_DN	H1-10 MCMBP GUCY1B1 FANCI CAPN6 EML2 ACSF2	2.51e-04	388	84	7	M15491
Coexpression	TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-C	2.67e-04	39	84	3	MM3758
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING	HLA-A HLA-B HLA-C	2.67e-04	39	84	3	MM3725
Coexpression	BENPORATH_NOS_TARGETS	CACNA2D1 TCF20 MTM1 TOP2A CDC7	2.80e-04	179	84	5	M14573
Coexpression	UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN	HLA-C IGHG1	2.81e-04	8	84	2	M48298
Coexpression	LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE	HLA-A HLA-C RIN2	2.88e-04	40	84	3	M41037
Coexpression	HOWLIN_CITED1_TARGETS_1_UP	HLA-A HLA-B HLA-C	3.10e-04	41	84	3	MM710
Coexpression	LIN_NPAS4_TARGETS_UP	HLA-A HLA-B RCAN1 HLA-C PFKFB4	3.10e-04	183	84	5	MM767
Coexpression	WIELAND_UP_BY_HBV_INFECTION	HLA-A HLA-B IGHG1 SLC7A7	3.41e-04	103	84	4	M11620
Coexpression	GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	COL2A1 HLA-A HLA-B HLA-C	3.41e-04	103	84	4	MM476
Coexpression	BENPORATH_OCT4_TARGETS	IL1RAPL1 CACNA2D1 TCF20 MTM1 TOP2A CDC7	3.44e-04	290	84	6	M17183
Coexpression	HU_GENOTOXIC_DAMAGE_4HR	HLA-A HLA-B HLA-C	3.57e-04	43	84	3	MM1204
Coexpression	WEST_ADRENOCORTICAL_TUMOR_UP	TNPO1 ABCC1 SLC20A1 FANCI CDK1 TOP2A	3.97e-04	298	84	6	M1918
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	COL5A2 PJA2 ABCC1 RIN2 WBP4 NECTIN3 MAPK8 TOP2A VPS13B SON	4.07e-04	856	84	10	M4500
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_PROXIMAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING	HLA-A HLA-B RCAN1 HLA-C SLC7A7	4.25e-04	196	84	5	MM3730
Coexpression	GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN	H1-10 HLA-A HLA-B HLA-C WBP4	4.35e-04	197	84	5	M9580
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-C	4.36e-04	46	84	3	MM3712
Coexpression	ZHAN_MULTIPLE_MYELOMA_PR_UP	FANCI CDK1 TOP2A	4.36e-04	46	84	3	M4888
Coexpression	GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN	PLA2R1 AMMECR1L CAPN6 CDK1 SON	4.45e-04	198	84	5	M7916
Coexpression	SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	COL5A2 MCMBP FANCI CDK1 TOP2A CDC7	4.49e-04	305	84	6	M19875
Coexpression	LEE_EARLY_T_LYMPHOCYTE_UP	RCAN1 FANCI CDK1 TOP2A	4.53e-04	111	84	4	M7357
Coexpression	GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP	GUCY1B1 FANCI CDK1 TOP2A CDC7	4.56e-04	199	84	5	M9419
Coexpression	GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN	H1-10 MCMBP MTM1 CDK1 CSGALNACT1	4.56e-04	199	84	5	M8113
Coexpression	GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN	CACNA2D1 DYNC2H1 CAPSL CSGALNACT1 TOP2A	4.56e-04	199	84	5	M7522
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HPROGM	COL2A1 FANCI CDK1 NECTIN3 DNAH7 TOP2A	4.65e-04	307	84	6	M39058
Coexpression	GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN	RIN2 CAPSL MAPK8 SLC7A7 TOP2A	4.66e-04	200	84	5	M9374
Coexpression	GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN	SLC20A1 ACP2 MYO1F SLC7A7 VPS13B	4.66e-04	200	84	5	M7658
Coexpression	GSE27786_BCELL_VS_NKTCELL_UP	MTMR14 C1orf52 PFKFB1 CSGALNACT1 SON	4.66e-04	200	84	5	M4808
Coexpression	GSE16385_MONOCYTE_VS_MACROPHAGE_DN	AMMECR1L MTM1 CAPN6 NCAM2 SON	4.66e-04	200	84	5	M7901
Coexpression	GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	ABCC1 PLA2R1 GUCY1B1 MYO1F SON	4.66e-04	200	84	5	M8264
Coexpression	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	WBP4 MYO1F PFKFB1 TOP2A RYR2	4.66e-04	200	84	5	M5168
Coexpression	GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN	MCMBP HLA-B SLC20A1 PRPF39 RYR3	4.66e-04	200	84	5	M6554
Coexpression	GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	PJA2 HLA-B MTM1 WBP4 VPS13B	4.66e-04	200	84	5	M5556
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN	FASN FANCI WBP4 CDK1 TOP2A	4.66e-04	200	84	5	M5592
Coexpression	GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN	HLA-B HLA-C WBP4 NCAM2 SLC7A7	4.66e-04	200	84	5	M3638
Coexpression	GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN	MTMR14 RIN2 UBR4 MYO1F SLC7A7	4.66e-04	200	84	5	M4486
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN	ABCC1 FASN CPS1 MAPK8 PRPF39	4.66e-04	200	84	5	M3833
Coexpression	GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP	ABCC1 CAPSL PFKFB1 DNAH7 RYR2	4.66e-04	200	84	5	M9169
Coexpression	GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP	ABCC1 HLA-A HLA-B KCNE1 UBR4	4.66e-04	200	84	5	M6115
Coexpression	BAUS_TFF2_TARGETS_UP	HLA-A HLA-B HLA-C	5.26e-04	49	84	3	MM1287
Coexpression	PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	HLA-A HLA-B HLA-C	5.26e-04	49	84	3	M8341
Coexpression	LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	COL5A2 UBR4 NRP2	5.26e-04	49	84	3	M2899
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	HLA-A HLA-B HLA-C	5.58e-04	50	84	3	MM3805
Coexpression	PUJANA_BRCA_CENTERED_NETWORK	FANCI CDK1 TOP2A CDC7	5.71e-04	118	84	4	M15305
Coexpression	MARTINEZ_RB1_TARGETS_UP	CACNA2D1 AMMECR1L TCF20 EML5 HLA-A HLA-B HLA-C CAPN6 PKDREJ	6.11e-04	741	84	9	MM1037
Coexpression	VANGURP_PANCREATIC_BETA_CELL	PRUNE2 ENTPD3 PFKFB2 NECTIN3	6.27e-04	121	84	4	M45030
Coexpression	GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	CDK1 TOP2A	6.56e-04	12	84	2	M629
Coexpression	IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR	ABCC1 FASN HLA-B HLA-C CAPSL NCAM2 DAGLA HSPA4	6.82e-04	600	84	8	MM1025
ToppCell	facs-Lung-EPCAM-24m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 FANCI YY2 ACSF2 PRPF39 PKDREJ DAGLA CSGALNACT1 NRP2	3.12e-11	167	84	9	961e722442d786ab15d1e490941d2be265a9057a
ToppCell	facs-Lung-EPCAM-24m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 FANCI YY2 ACSF2 PRPF39 PKDREJ DAGLA CSGALNACT1 NRP2	3.12e-11	167	84	9	3760efc35d4e7e9c2da1a20f9795ddea397e2206
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	COL2A1 COL5A2 EML5 DYNC2H1 CAPN6 ADGRB3 RYR2 RYR3	4.00e-09	198	84	8	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 COL5A2 PLA2R1 GUCY1B1 NCAM2 RYR2 NRP2	7.65e-08	191	84	7	fa380a8752de158974b2ae5e741573439719cc0d
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 COL5A2 GUCY1B1 NCAM2 RYR2 NRP2	1.62e-06	190	84	6	7986586b7c82e91c71102cc8c4d7a689ae63ab4d
ToppCell	BLOOD--(1)_T_cell-(1)_gd_T_cells\|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C IGHG1 SLC20A1 MYO1F	1.67e-06	191	84	6	c6914e2733de20ecd6d1d27786b9a03992d612e7
ToppCell	Enterocyte_Progenitors-C_06\|Enterocyte_Progenitors / shred on cell type and cluster	PRUNE2 HLA-A HLA-C IGHG1 CAPN6 CSGALNACT1	1.72e-06	192	84	6	b9938e1a929c00628cc6ebfdf10cf285167f445c
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CACNA2D1 UGGT1 ENTPD3 PFKFB2 SON	1.83e-06	194	84	6	92b39a935e8c577eb1123d706d168fa13cf3344c
ToppCell	Monocytes-Phagocytic_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	HLA-A HLA-B HLA-C KCNE1 ACP2 SLC38A6	1.83e-06	194	84	6	40dbfdf1d7e6b73d120d8f802f08e573fe9a739e
ToppCell	BLOOD--(2)_B_cell-(2)_Memory_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C IGHG1 MYO1F CSGALNACT1	1.88e-06	195	84	6	c25391931659881d4104b06cf07cb44efa635e39
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 PLA2R1 CACNA2D1 ADGRB3 NCAM2 RYR2	2.00e-06	197	84	6	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL5A2 PLA2R1 CACNA2D1 ADGRB3 NCAM2 RYR2	2.06e-06	198	84	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-neutrophil-neutrophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HLA-A HLA-B HLA-C KCNE1 MYO1F SLC7A7	2.12e-06	199	84	6	7cbd98dd10c91584dee04593910031e90c1340b8
ToppCell	10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HLA-A HLA-B HLA-C KCNE1 MYO1F SLC7A7	2.18e-06	200	84	6	4984d27b3768be3b8fca3391cd2b7ab1749e2913
ToppCell	facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL2A1 HFM1 CDK1 TOP2A RYR2	9.01e-06	148	84	5	5983c4546f527a0b599cfcbd8a6cb937a1d6f895
ToppCell	(5)_Plasma-(5)_Plasma_IgG\|(5)_Plasma / Spleen cell shreds - cell class (v1) and cell subclass (v1)	H1-10 HLA-B HLA-C IGHG1	9.44e-06	70	84	4	bfe020c111a27337ed4dc6ee59b74bc36b03eb49
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high\|E18.5-samps / Age Group, Lineage, Cell class and subclass	IL1RAPL1 PRUNE2 HFM1 CASZ1 RYR2	1.09e-05	154	84	5	212c340a096a3a9669d1aebd61c045cf1402a868
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL12 EML5 MTM1 ENTPD3 RYR3	1.28e-05	159	84	5	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL12 EML5 MTM1 ENTPD3 RYR3	1.28e-05	159	84	5	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	YY2 RAB15 CDK1 TOP2A CDC7	1.48e-05	164	84	5	4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TTLL12 EML5 MTM1 ENTPD3 RYR3	1.57e-05	166	84	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TTLL12 EML5 MTM1 ENTPD3 RYR3	1.57e-05	166	84	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 FANCI CDK1 TOP2A CDC7	1.81e-05	171	84	5	b0373ed8283ee1792b6a490bff93906546978593
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL5A2 FANCI CDK1 TOP2A CDC7	1.81e-05	171	84	5	b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCell	(6)_Endothelial_cells-(6)_Endothelial-E\|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	HLA-A HLA-B HLA-C RIN2 CASZ1	1.97e-05	174	84	5	4a1b67ce5ea353b3f81f59fa57da07668146afca
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PLA2R1 GUCY1B1 CDK1 DAGLA TOP2A	2.02e-05	175	84	5	15c69dd5635c9251c535f1e22467712e9667ae92
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DYNC2H1 CAPSL DHRS9 AKAP3 DNAH7	2.08e-05	176	84	5	dee780cfa85234a7cd7bf440b66b84cec959893e
ToppCell	Severe-CD4+_T_activated\|Severe / Disease group and Cell class	HLA-A HLA-B HLA-C NCAM2 RYR2	2.14e-05	177	84	5	a08f170f1143fcdd7d0842a54d9b807a4548f8b7
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	HLA-A HLA-B HLA-C NCAM2 RYR2	2.20e-05	178	84	5	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HLA-A HLA-B HLA-C MYO1F AKAP3	2.20e-05	178	84	5	c4a2e9a440e941e82bb35abefa054e07ad250d45
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GCNT3 FANCI DHRS9 CDK1 TOP2A	2.38e-05	181	84	5	e0c46e2d52c97893e5894a51d2699e8a8a11eefc
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	H1-10 CAPN6 YY2 GPR37L1 DAGLA	2.44e-05	182	84	5	a1c0e4090a9e7aa4941a40c817d178de144888b6
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	GCNT3 CDK1 USP48 TOP2A CDC7	2.51e-05	183	84	5	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 NCAM2 CPS1 RYR2 RYR3	2.57e-05	184	84	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 NCAM2 CPS1 RYR2 RYR3	2.57e-05	184	84	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL2A1 NCAM2 CPS1 RYR2 RYR3	2.57e-05	184	84	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	human_hepatoblastoma-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	IL1RAPL1 COL5A2 CACNA2D1 GUCY1B1 ADGRB3	2.71e-05	186	84	5	cb1fc4b9140666b43415e21c9b434dc9b144e9d0
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 COL5A2 GUCY1B1 ADGRB3 RYR2	2.78e-05	187	84	5	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	pdx-Tumor_cells-T5\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ABCC1 TCF20 PFKFB4 CASZ1 NRP2	2.78e-05	187	84	5	7e376831a11ee72ed87abcdac631ca46ae29c250
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	2.78e-05	187	84	5	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IL1RAPL1 COL5A2 GUCY1B1 ADGRB3 RYR2	2.78e-05	187	84	5	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_NK-natural_killer_cell-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	HLA-A HLA-B HLA-C MYO1F PKDREJ	2.85e-05	188	84	5	a29c43a91ed1364a09d5abab6efa51b8061bce74
ToppCell	RA-11._Adipocyte\|World / Chamber and Cluster_Paper	PRUNE2 FASN KCNE1 PFKFB1 ACSF2	2.85e-05	188	84	5	4dac9d636e5cad4cda540b93d4bfed6b5732c880
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 EML5 ENTPD3 PFKFB2 SON	2.85e-05	188	84	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	Control-B_intermediate-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	HLA-B IGHG1 UBR4 DHRS9 ACSF2	2.93e-05	189	84	5	11cb9a16f1de8f60af2073ed7ea6d4f41c02f299
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.00e-05	190	84	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	FANCI CDK1 CASZ1 TOP2A CDC7	3.00e-05	190	84	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	facs-Pancreas\|facs / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CACNA2D1 EML5 DYNC2H1 ENTPD3	3.08e-05	191	84	5	d48e5f67d384226add7d7fb2a124954136e09a82
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CACNA2D1 UGGT1 PFKFB2 NECTIN3	3.08e-05	191	84	5	f76f3f5c7902a3659d8cbe470f96ce57c8a6744d
ToppCell	COVID-19-kidney-Myeloid\|kidney / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C KCNE1 MYO1F	3.16e-05	192	84	5	441cd1ec171f643b28e1f6f9c04def629cc7391b
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)\|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	PRUNE2 DHRS9 PFKFB2 CSGALNACT1 TOP2A	3.16e-05	192	84	5	072281344d58e85c9a290750b488d0c101f75d54
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 CACNA2D1 ENTPD3 PFKFB2 SON	3.16e-05	192	84	5	1304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	COL5A2 UBR4 ADGRB3 ZNF343 HSPA4	3.16e-05	192	84	5	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	ILEUM-non-inflamed-(2)_B_cell-(2)_Memory_B_cells\|(2)_B_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C IGHG1 MYO1F	3.16e-05	192	84	5	37d0d0fdd6bc3114d546020b472b6df9392392f4
ToppCell	COPD-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	COL5A2 ADGRB3 NCAM2 RYR2 NRP2	3.16e-05	192	84	5	62904f94dfce430456f05066522cbf9bd29f4d7e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 COL5A2 PLA2R1 NCAM2 NRP2	3.23e-05	193	84	5	9f69edc97b868d23998abc98928a2e89a885ef8a
ToppCell	11.5-Airway-Mesenchymal-Cartilage\|Airway / Age, Tissue, Lineage and Cell class	COL2A1 CAPN6 NCAM2 ACSF2 CSGALNACT1	3.23e-05	193	84	5	d4779d92a4dd4b8b656383e6f4fce76d3bd70931
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 UGGT1 UBR4 ENTPD3 SON	3.23e-05	193	84	5	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.23e-05	193	84	5	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EML5 UGGT1 UBR4 ENTPD3 SON	3.23e-05	193	84	5	fe451b3295d77b2bd1ac25cf29310c85835a45fe
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.23e-05	193	84	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HLA-B HLA-C DHRS9 RAB15	3.32e-05	194	84	5	1a188e52f2f0b6eca3e8d4a4671d9beab0fbbb88
ToppCell	(3)_Chondrocytes-(33)_Chondro-prol/rest\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	COL2A1 H1-10 FASN CDK1 TOP2A	3.32e-05	194	84	5	c093c5e161b97ad770bfbaad3023eba4537101b5
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.32e-05	194	84	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 COL5A2 PLA2R1 NCAM2 NRP2	3.32e-05	194	84	5	71d3c7448b1734de54187f902f65649f9283bd4c
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IL1RAPL1 COL5A2 ADGRB3 NCAM2 NRP2	3.32e-05	194	84	5	8c37bedb23285735ff3828db3889897fada8c95d
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|lung / Disease (COVID-19 only), tissue and cell type	PRUNE2 COL5A2 CACNA2D1 GUCY1B1 RYR2	3.32e-05	194	84	5	5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3
ToppCell	T_cells-GZMK+_T_cells\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HLA-A HLA-B HLA-C IGHG1 MYO1F	3.40e-05	195	84	5	003ea7ddec6c1c98d2f6470bb51ebd97450eb936
ToppCell	droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENTPD3 RAB15 CAPN5 PFKFB2 CASZ1	3.40e-05	195	84	5	d6e2a5a15bea16de5f7ff09318c67d46ea923203
ToppCell	3'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRUNE2 HLA-B HLA-C DHRS9 RAB15	3.40e-05	195	84	5	3365768101454060b9ea96ef6b426c76c150bc8f
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 DYNC2H1 UGGT1 PFKFB2 SON	3.40e-05	195	84	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA2D1 DYNC2H1 UGGT1 PFKFB2 SON	3.40e-05	195	84	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	COVID-19-lung-Proliferative_fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	COL5A2 FANCI NCAM2 CDK1 TOP2A	3.48e-05	196	84	5	2ce8a787f2731faa913d20342d73041d59468f27
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.48e-05	196	84	5	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	severe-CD8+_Tem\|World / disease stage, cell group and cell class	HLA-A HLA-B HLA-C IGHG1 MYO1F	3.48e-05	196	84	5	b8156d31312660fe9c071cb10d7ef22af672c6c8
ToppCell	COVID-19-lung-Proliferative_fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL5A2 FANCI NCAM2 CDK1 TOP2A	3.48e-05	196	84	5	ca91d5e325875e7444809b80fcbd491d8899ea36
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	COL5A2 SLC20A1 FANCI CDK1 TOP2A	3.57e-05	197	84	5	1bb8f9535a9ab6c7a444bcbe346fcc0a13b09bdf
ToppCell	wk_08-11-Hematologic-Myeloid-APOE+_Mac1\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	HLA-A HLA-B HLA-C ACP2 CASZ1	3.57e-05	197	84	5	121ec3f6d978de2f6c2cc397f7327d2e5587ab8b
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.57e-05	197	84	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	NS-critical-LOC-Myeloid-Macrophage\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ACP2 RIN2 SLC7A7 SLC38A6 NRP2	3.57e-05	197	84	5	5fb0696376a5501b7c87e0f2f5e4fff3da2903f2
ToppCell	Sigmoid-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	CACNA2D1 IGHG1 ENTPD3 SLC7A7 RYR3	3.65e-05	198	84	5	305d7ae9b070ac7211638a5282374c02bf13af40
ToppCell	(2)_NK/T-(20)_NK_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	HLA-A HLA-B HLA-C RIN2 MYO1F	3.65e-05	198	84	5	2e4851e49457940e841660c5d781499ffb4a2bf1
ToppCell	10x_3'_v3\|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	H1-10 HLA-A HLA-B HLA-C SON	3.65e-05	198	84	5	aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCell	(2)_NK/T-(200)_CD56+_NK_cell\|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)	HLA-A HLA-B HLA-C RIN2 MYO1F	3.65e-05	198	84	5	03477a6356a3c08c6e723165c0aac3464ef01667
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.65e-05	198	84	5	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	COL5A2 CACNA2D1 ADGRB3 NCAM2 RYR2	3.74e-05	199	84	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HLA-A HLA-B HLA-C MYO1F NRP2	3.74e-05	199	84	5	155b03b859157013e9142e9248551369127d9204
ToppCell	10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HLA-A HLA-B HLA-C MYO1F SLC7A7	3.83e-05	200	84	5	62e9ca7cf4f49fc8957740acee41a1e530f10541
ToppCell	distal-Endothelial-Capillary_Aerocyte-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	AMER2 HLA-A HLA-B HLA-C RIN2	3.83e-05	200	84	5	0656906d16b0df19c0511965b5d18e9eab3cb168
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell\|GW12 / Sample Type, Dataset, Time_group, and Cell type.	TTLL12 PRUNE2 EML5 SLC7A7 DNAH7	3.83e-05	200	84	5	6b7314c425f6b40f1301dd39cc02b0436e96a2ec
ToppCell	Control-B_memory-6\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	IGHG1 DHRS9 MYO1F ACSF2	1.28e-04	136	84	4	94f23bef50c0beb54ed39b1a4b340f7aec4e75cd
ToppCell	BLOOD--(0)_NK_cell-(0)_NK_cells_(CD56dim-like)\|(0)_NK_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	HLA-A HLA-B HLA-C MYO1F	1.63e-04	145	84	4	6dd81d53d006fcc206a10969374a11c372f92133
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C MYO1F	1.86e-04	150	84	4	fdbfc8f743cf848978cf0488493f6df60be53982
ToppCell	LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT2_Progenitor\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ENTPD3 AKAP3 CDK1 TOP2A	1.91e-04	151	84	4	c06a54afe918b14f885d6a85fbcf81e80f33afae
ToppCell	droplet-Lung-nan-3m-Myeloid-dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FANCI CAPRIN2 YY2 CDC7	1.96e-04	152	84	4	77b319f594d5e4df29034bbf69c7490076f89dd3
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	HLA-B HLA-C KCNE1 MYO1F	2.01e-04	153	84	4	764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|390C / Donor, Lineage, Cell class and subclass (all cells)	HLA-A HLA-B HLA-C MYO1F	2.01e-04	153	84	4	ce7a23c687e9e7d83d244046de19c854caded09b
ToppCell	TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3\|TCGA-Thryoid / Sample_Type by Project: Shred V9	PLA2R1 DNAH7 CSGALNACT1 RYR2	2.06e-04	154	84	4	4e9203c220a44c70cd7979796a0b461991422257
ToppCell	Control-Epithelial_airway-Ciliated_cells-Ciliated\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 CAPSL DHRS9 DNAH7	2.06e-04	154	84	4	4e3bc24043144143842627cacf6f90dda2228910
ToppCell	Control-Epithelial_airway-Ciliated_cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSNAXIP1 CAPSL DHRS9 DNAH7	2.06e-04	154	84	4	7556a4b2b062da5ae7ec2bbb66e745e7662db628
Computational	Genes in the cancer module 293.	HLA-A HLA-B HLA-C	3.51e-05	12	60	3	MODULE_293
Computational	Genes in the cancer module 143.	HLA-A HLA-B HLA-C	5.76e-05	14	60	3	MODULE_143
Drug	chloro-m-cresol	CACNA2D1 RYR2 RYR3	9.61e-07	6	84	3	CID000012008
Drug	MBED	HSPA4 RYR2 RYR3	9.61e-07	6	84	3	CID000129958
Drug	glipentide	PFKFB1 PFKFB2 PFKFB4	1.68e-06	7	84	3	CID000065779
Drug	Azumoleno	CACNA2D1 RYR2 RYR3	1.68e-06	7	84	3	CID000056259
Drug	melarsen oxide	ABCC1 PFKFB1 PFKFB2 PFKFB4	1.73e-06	24	84	4	CID000030830
Drug	Curcumin	COL2A1 COL5A2 H1-10 ABCC1 FASN SLC20A1 FANCI NHLRC2 CDK1 PFKFB4 MAPK8 HSPA4 EP300 TOP2A	2.57e-06	850	84	14	ctd:D003474
Drug	2-MP	PFKFB1 PFKFB2 PFKFB4	2.68e-06	8	84	3	CID003015569
Drug	Zidovudine	ABCC1 FASN HLA-A HLA-B GUCY1B1 SLC20A1 CDK1 MAPK8 SLC7A7 CSGALNACT1 SLC38A6	3.34e-06	521	84	11	ctd:D015215
Drug	Laevuflex	FASN GK2 SLC20A1 ACP2 PFKFB1 PFKFB2 PFKFB4 MAPK8	7.45e-06	272	84	8	CID000003426
Drug	fructose 2-phosphorothioate 6-phosphate	PFKFB1 PFKFB2 PFKFB4	7.82e-06	11	84	3	CID000195184
Drug	R 478	HSPA4 RYR2 RYR3	7.82e-06	11	84	3	CID000084223
Drug	8-amino-cADPR	HLA-B RYR2 RYR3	7.82e-06	11	84	3	CID003081323
Drug	lomefloxacin	HLA-B TOP2A	1.35e-05	2	84	2	ctd:C053091
Drug	carboxytolbutamide	PFKFB1 PFKFB2 PFKFB4	1.71e-05	14	84	3	CID000159651
Drug	PK-F	PFKFB1 PFKFB2 PFKFB4	1.71e-05	14	84	3	CID000448133
Drug	FPL 64176	CACNA2D1 RYR2 RYR3	2.13e-05	15	84	3	CID000003423
Drug	Thr-Ala	PFKFB1 PFKFB2 PFKFB4	2.13e-05	15	84	3	CID006427021
Drug	AC1L1FCN	HLA-A HLA-B HLA-C	2.13e-05	15	84	3	CID000003178
Drug	2-methoxy-5-(2',3',4'-trimethoxyphenyl)tropone	TNPO1 PRUNE2 COL5A2 PJA2 HLA-A HLA-B HLA-C GUCY1B1	2.41e-05	320	84	8	ctd:C030370
Drug	dibenzyl succinate	PFKFB1 PFKFB2 PFKFB4	2.62e-05	16	84	3	CID000007653
Drug	Thimerosal	H1-10 FASN EML5 HLA-A HLA-B UGGT1 CAPN5 CDK1 PFKFB2 PFKFB4 CPS1 MAPK8 TOP2A RYR3 SON	2.94e-05	1199	84	15	ctd:D013849
Drug	N-bromoacetylethanolamine phosphate	PFKFB1 PFKFB2 PFKFB4	3.17e-05	17	84	3	CID000188343
Drug	AC1L1AO2	PFKFB1 PFKFB2 PFKFB4	3.80e-05	18	84	3	CID000001073
Drug	brazilin	PFKFB1 PFKFB2 PFKFB4	3.80e-05	18	84	3	CID000073384
Drug	cis-diammineplatinum(II	RYR2 RYR3	4.03e-05	3	84	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR2 RYR3	4.03e-05	3	84	2	CID002750949
Drug	8N3-cADPR	RYR2 RYR3	4.03e-05	3	84	2	CID000127713
Drug	aminodantrolene	RYR2 RYR3	4.03e-05	3	84	2	CID009570289
Drug	2-hydroxycarbazole	RYR2 RYR3	4.03e-05	3	84	2	CID000093551
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR2 RYR3	4.03e-05	3	84	2	CID005748312
Drug	3-phosphohistidine	ACP2 PFKFB1 PFKFB2 PFKFB4	5.87e-05	57	84	4	CID000123911
Drug	indo-1/AM	CACNA2D1 RYR2 RYR3	6.14e-05	21	84	3	CID000123918
Drug	hydralazine	CACNA2D1 GUCY1B1 MAPK8 HSPA4 SLC38A6 EP300	6.57e-05	186	84	6	CID000003637
Drug	geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A	DHRS9 CPS1 SLC7A7 PRPF39 HSPA4 CSGALNACT1	6.57e-05	186	84	6	1228_UP
Drug	Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A	RCAN1 DYNC2H1 ENTPD3 CPS1 USP48 VPS13B	7.61e-05	191	84	6	2055_DN
Drug	IAA-94	CACNA2D1 HLA-A RYR2 RYR3	7.66e-05	61	84	4	CID000003667
Drug	PA-J	HLA-A HLA-C	8.03e-05	4	84	2	CID000447261
Drug	PCB74	RYR2 RYR3	8.03e-05	4	84	2	CID000036218
Drug	148504-47-6	RYR2 RYR3	8.03e-05	4	84	2	CID006444275
Drug	SC 38249	RYR2 RYR3	8.03e-05	4	84	2	CID000134834
Drug	AC1L1U7A	RYR2 RYR3	8.03e-05	4	84	2	CID000035682
Drug	Parbendazole [14255-87-9]; Up 200; 16.2uM; PC3; HT_HG-U133A	KCNE1 UBR4 ADGRB3 NCAM2 DNAH7 NRP2	8.29e-05	194	84	6	3799_UP
Drug	(-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A	TSNAXIP1 GPR37L1 CPS1 MAPK8 VPS13B RYR2	8.29e-05	194	84	6	6833_UP
Drug	Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A	GUCY1B1 WBP4 EML2 CPS1 CSGALNACT1 EP300	8.53e-05	195	84	6	1831_UP
Drug	Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; MCF7; HT_HG-U133A	ABCC1 RCAN1 MYO1F EML2 NECTIN3 RYR2	9.02e-05	197	84	6	4717_DN
Drug	PNU-0230031 [267429-39-0]; Up 200; 1uM; MCF7; HT_HG-U133A	TSNAXIP1 GK2 PFKFB2 CPS1 RYR2 NRP2	9.02e-05	197	84	6	4757_UP
Drug	Dichlorphenamide [120-97-8]; Down 200; 13.2uM; PC3; HT_HG-U133A	MTM1 EML2 CPS1 DAGLA CASZ1 NRP2	9.02e-05	197	84	6	6686_DN
Drug	Benzonatate [104-31-4]; Down 200; 6.6uM; PC3; HT_HG-U133A	ABCC1 MTM1 PFKFB2 USP48 HSPA4 CASZ1	9.02e-05	197	84	6	1801_DN
Drug	succinylcholine	CACNA2D1 SLC38A6 RYR2 RYR3	9.25e-05	64	84	4	CID000005314
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A	DYNC2H1 MTM1 EML2 NECTIN3 MAPK8 DNAH7	9.28e-05	198	84	6	1468_UP
Drug	Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	COL2A1 GUCY1B1 MTM1 MYO1F DNAH7 RYR2	9.28e-05	198	84	6	5786_DN
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A	COL2A1 COL5A2 ZNF343 PFKFB2 CPS1 NRP2	9.28e-05	198	84	6	5635_UP
Drug	Diethylstilbestrol [56-53-1]; Up 200; 15uM; HL60; HT_HG-U133A	GCNT3 DYNC2H1 UGGT1 EML2 PFKFB2 MAPK8	9.54e-05	199	84	6	2567_UP
Drug	Kawain [500-64-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	PRUNE2 RCAN1 DYNC2H1 DHRS9 GPR37L1 USP48	9.54e-05	199	84	6	2337_UP
Drug	wortmannin; Down 200; 0.01uM; HL60; HG-U133A	RCAN1 MTM1 CAPN5 MAPK8 HSPA4 CASZ1	9.54e-05	199	84	6	389_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A	FANCI ACP2 NHLRC2 SLC7A7 CASZ1 SON	9.54e-05	199	84	6	1588_DN
Drug	Acrylamide	COL2A1 GUCY1B1 KCNE1 MAPK8 TOP2A RYR3	9.54e-05	199	84	6	ctd:D020106
Drug	Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A	PRUNE2 CACNA2D1 ENTPD3 ADGRB3 PFKFB2 NRP2	9.54e-05	199	84	6	6024_UP
Drug	T0702	KCNE1 RYR2 RYR3	1.05e-04	25	84	3	CID000005908
Drug	Apigenin	ABCC1 FASN CDK1 MAPK8 USP48 EP300	1.18e-04	207	84	6	ctd:D047310
Drug	adenosine 3',5'-cyclic phosphate	CACNA2D1 FASN GUCY1B1 KCNE1 SLC20A1 CDK1 PFKFB1 PFKFB2 PFKFB4 CPS1 MAPK8 EP300	1.20e-04	907	84	12	CID000000274
Drug	mitiglinide	PFKFB1 PFKFB2 PFKFB4	1.33e-04	27	84	3	CID000121891
Drug	pCa 10	HLA-A RYR2	1.34e-04	5	84	2	CID000147030
Drug	PMSD	HLA-A HLA-B	1.34e-04	5	84	2	CID000083890
Drug	brinzolamide	HLA-A HLA-B	1.34e-04	5	84	2	ctd:C111827
Drug	flecainide	CACNA2D1 KCNE1 RYR2 RYR3	1.39e-04	71	84	4	CID000003355
Drug	nicorandil	CACNA2D1 HLA-A GUCY1B1 KCNE1	1.39e-04	71	84	4	CID000047528
Drug	AC1L3V67	COL2A1 ABCC1 EP300	1.48e-04	28	84	3	CID000147439
Drug	phorbol acetate myristate	COL2A1 IL1RAPL1 ABCC1 CACNA2D1 SLC20A1 CDK1 PFKFB1 PFKFB2 PFKFB4 MAPK8 DAGLA HSPA4 EP300 RYR2 RYR3	1.67e-04	1399	84	15	CID000004792
Drug	benzoate	TCF20 RCAN1 PFKFB1 PFKFB2 PFKFB4 CPS1	1.69e-04	221	84	6	CID000000242
Drug	zaprinast	TNPO1 ABCC1 GUCY1B1 RYR2 RYR3	1.77e-04	141	84	5	CID000005722
Drug	2,4-xylidinothiazoline	COL2A1 RYR2 RYR3	1.83e-04	30	84	3	CID000099296
Drug	hexamethylene diisocyanate	GK2 HLA-A SLC38A6	1.83e-04	30	84	3	CID000013192
Drug	1 sulfonylurea	ABCC1 CACNA2D1 PFKFB1 PFKFB2 PFKFB4	1.89e-04	143	84	5	CID011819083
Drug	glycerol-3-phosphate	FASN GK2 ACP2 PFKFB1 PFKFB2 PFKFB4	1.91e-04	226	84	6	CID000000754
Drug	AC1O528X	RYR2 RYR3	2.00e-04	6	84	2	CID006475857
Drug	NSC114784	RYR2 RYR3	2.00e-04	6	84	2	CID000419425
Drug	indomethacin	IL1RAPL1 PJA2 ABCC1 CACNA2D1 HLA-A GUCY1B1 DHRS9 ENTPD3 DAGLA HSPA4	2.24e-04	690	84	10	CID000003715
Drug	3-(1H-pyrrole-2-carboxylate	CACNA2D1 GUCY1B1 KCNE1 HSPA4 RYR2 RYR3	2.25e-04	233	84	6	CID000005114
Drug	glycerol	FASN GK2 HLA-B ACP2 NCAM2 PFKFB1 PFKFB2 PFKFB4 DAGLA HSPA4 NRP2	2.30e-04	829	84	11	CID000000753
Drug	AC1L9XAW	ABCC1 CACNA2D1 SLC38A6	2.44e-04	33	84	3	CID000477669
Drug	CNS 1145	CACNA2D1 RYR2 RYR3	2.44e-04	33	84	3	CID000190902
Drug	IHC-64	CACNA2D1 RYR2 RYR3	2.44e-04	33	84	3	CID000162753
Drug	[[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate	RYR2 RYR3	2.79e-04	7	84	2	CID009547999
Drug	Br2BAPTA	RYR2 RYR3	2.79e-04	7	84	2	CID003081001
Drug	xanthatin	CDK1 TOP2A	2.79e-04	7	84	2	ctd:C022186
Drug	CHEBI:564108	CACNA2D1 RYR3	2.79e-04	7	84	2	CID006400637
Drug	mantATP	PFKFB1 PFKFB2 PFKFB4	2.91e-04	35	84	3	CID000123756
Drug	baicalein	ABCC1 FASN CDK1 MAPK8	3.04e-04	87	84	4	ctd:C006680
Drug	Etoposide	ABCC1 FASN HLA-A HLA-B RCAN1 CPS1 CSGALNACT1 EP300 TOP2A	3.12e-04	587	84	9	ctd:D005047
Drug	quinocetone	CACNA2D1 FASN DYNC2H1 CAPN6 CSGALNACT1 RYR3	3.14e-04	248	84	6	ctd:C502851
Drug	sodium ferulate	COL2A1 RTP3 MAPK8 SLC38A6	3.18e-04	88	84	4	CID000000709
Drug	magnesium	COL2A1 TNPO1 ABCC1 CACNA2D1 GUCY1B1 KCNE1 ACP2 ENTPD3 PFKFB1 PFKFB2 PFKFB4 CPS1 RYR2 RYR3	3.29e-04	1325	84	14	CID000000888
Drug	Dimethylnitrosamine	PRUNE2 COL5A2 RTP3 GCNT3 SLC20A1 ACP2 MYO1F CDK1 CPS1 MAPK8 TOP2A	3.30e-04	865	84	11	ctd:D004128
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B HLA-C	7.45e-07	7	83	3	DOID:0081267 (implicated_via_orthology)
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B HLA-C EP300	1.31e-06	29	83	4	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C EP300	1.31e-06	29	83	4	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B HLA-C EP300	1.31e-06	29	83	4	C3658302
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B HLA-C EP300	1.31e-06	29	83	4	C0014518
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B HLA-C EP300	1.51e-06	30	83	4	C0038325
Disease	beta-2 microglobulin measurement	HLA-A HLA-B HLA-C	3.48e-06	11	83	3	EFO_0005197
Disease	–	HLA-A HLA-B	7.82e-06	2	83	2	608579
Disease	spondyloarthropathy (is_implicated_in)	COL2A1 HLA-B	7.82e-06	2	83	2	DOID:1123 (is_implicated_in)
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	7.82e-06	2	83	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	7.82e-06	2	83	2	cv:CN077964
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	2.34e-05	3	83	2	DOID:3529 (implicated_via_orthology)
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	2.34e-05	3	83	2	DOID:8545 (implicated_via_orthology)
Disease	Synovial Hypertrophy	COL2A1 HLA-B	2.34e-05	3	83	2	C0410574
Disease	Synovitis	COL2A1 HLA-B	2.34e-05	3	83	2	C0039103
Disease	Malignant neoplasm of breast	ABCC1 FASN DYNC2H1 UBR4 WBP4 YY2 PFKFB4 SLC7A7 PKDREJ EP300 TOP2A VPS13B	4.55e-05	1074	83	12	C0006142
Disease	Malignant Glioma	HLA-A HLA-B HLA-C TOP2A	4.63e-05	70	83	4	C0555198
Disease	mixed gliomas	HLA-A HLA-B HLA-C TOP2A	4.63e-05	70	83	4	C0259783
Disease	gamma-glutamylcitrulline measurement	ABCC1 CPS1	4.67e-05	4	83	2	EFO_0800690
Disease	Centronuclear myopathy	MTMR14 MTM1	4.67e-05	4	83	2	cv:C0175709
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	4.67e-05	4	83	2	DOID:0050426 (is_implicated_in)
Disease	myeloid white cell count	TTLL12 PRUNE2 PLA2R1 HLA-A HLA-B HLA-C GUCY1B1 CAPSL HFM1 NHLRC2 CPS1	6.26e-05	937	83	11	EFO_0007988
Disease	allergic asthma (is_implicated_in)	HLA-B HLA-C	7.77e-05	5	83	2	DOID:9415 (is_implicated_in)
Disease	response to anticonvulsant	ABCC1 HLA-A RIN2 C1orf52	9.91e-05	85	83	4	GO_0036277
Disease	Glioma	HLA-A HLA-B HLA-C TOP2A	1.08e-04	87	83	4	C0017638
Disease	mental or behavioural disorder, substance abuse	HFM1 CDC7	1.16e-04	6	83	2	EFO_0000677, MONDO_0002491
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	HLA-A HLA-B HLA-C NHLRC2 CPS1 CSGALNACT1	1.75e-04	291	83	6	EFO_0008317, EFO_0020946
Disease	immunoglobulin isotype switching measurement	HLA-B IGHG1 UBR4	2.62e-04	44	83	3	EFO_0010128
Disease	Liver Cirrhosis, Experimental	PRUNE2 COL5A2 RTP3 TCF20 SLC20A1 MYO1F CDK1 CPS1 CSGALNACT1	3.27e-04	774	83	9	C0023893
Disease	platelet crit	COL2A1 TTLL12 TNPO1 PLA2R1 HLA-A HLA-B HFM1 NHLRC2 CPS1 CDC7	3.37e-04	952	83	10	EFO_0007985
Disease	VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)	KCNE1 RYR2	3.47e-04	10	83	2	C1631597
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	HFM1 DAGLA CDC7	3.82e-04	50	83	3	EFO_0010732
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	HLA-A HLA-B CPS1 CSGALNACT1	3.85e-04	121	83	4	EFO_0008595, EFO_0020943
Disease	glutamine measurement, amino acid measurement	TNPO1 CPS1	4.23e-04	11	83	2	EFO_0005134, EFO_0009768
Disease	Long QT Syndrome	KCNE1 RYR2	4.23e-04	11	83	2	C0023976
Disease	human papilloma virus infection, oropharynx cancer	HLA-B CPS1 SLC7A7	4.54e-04	53	83	3	EFO_0001668, EFO_1001931
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	HLA-A HLA-B ACP2 NHLRC2 CSGALNACT1	5.81e-04	239	83	5	EFO_0008317, EFO_0020945
Disease	Autosomal Dominant Myotubular Myopathy	MTMR14 MTM1	5.98e-04	13	83	2	C3661489
Disease	Centronuclear myopathy	MTMR14 MTM1	5.98e-04	13	83	2	C0175709
Disease	X-linked centronuclear myopathy	MTMR14 MTM1	5.98e-04	13	83	2	C0410203
Disease	Myopathy, Centronuclear, 1	MTMR14 MTM1	5.98e-04	13	83	2	C4551952
Disease	glutaroyl carnitine measurement	ABCC1 CPS1	5.98e-04	13	83	2	EFO_0021005
Disease	Congenital Structural Myopathy	MTMR14 MTM1	5.98e-04	13	83	2	C0752282
Disease	melanoma	COL2A1 IL1RAPL1 FASN UBR4 EP300	6.86e-04	248	83	5	C0025202
Disease	Myopathy, Centronuclear, Autosomal Dominant	MTMR14 MTM1	6.96e-04	14	83	2	C1834558
Disease	Tubular Aggregate Myopathy	MTMR14 MTM1	6.96e-04	14	83	2	C0410207
Disease	cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement	HLA-A HLA-B IGHG1 CPS1	7.41e-04	144	83	4	EFO_0004611, EFO_0020943
Disease	Autosomal Recessive Centronuclear Myopathy	MTMR14 MTM1	8.02e-04	15	83	2	C3645536
Disease	killer cell immunoglobulin-like receptor 2DS2 measurement	HLA-B HLA-C	8.02e-04	15	83	2	EFO_0801746
Disease	glutarylcarnitine (C5-DC) measurement	ABCC1 CPS1	1.03e-03	17	83	2	EFO_0800030
Disease	metabolite measurement, diet measurement	HLA-B CPS1 DAGLA	1.07e-03	71	83	3	EFO_0004725, EFO_0008111
Disease	Congenital Fiber Type Disproportion	MTMR14 MTM1	1.16e-03	18	83	2	C0546264
Disease	Cannabis use, age at onset	HLA-B RYR2	1.30e-03	19	83	2	EFO_0004847, EFO_0007585
Disease	citrate measurement	IL1RAPL1 PFKFB2 CPS1	1.45e-03	79	83	3	EFO_0010114
Disease	COVID-19 (is_implicated_in)	HLA-B HLA-C	1.59e-03	21	83	2	DOID:0080600 (is_implicated_in)
Disease	mental or behavioural disorder	COL2A1 CACNA2D1 TCF20 RIN2	1.66e-03	179	83	4	EFO_0000677
Disease	Drug toxicity	ABCC1 HLA-B HLA-C	1.74e-03	84	83	3	C0013221
Disease	Adverse reaction to drug	ABCC1 HLA-B HLA-C	1.74e-03	84	83	3	C0041755
Disease	gamma-glutamylglutamine measurement	TNPO1 ABCC1	1.74e-03	22	83	2	EFO_0021138
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-A HLA-B HLA-C NHLRC2 CSGALNACT1	1.77e-03	307	83	5	EFO_0004612, EFO_0020946
Disease	susceptibility to Mycobacterium tuberculosis infection measurement	HLA-A HLA-B HLA-C	1.86e-03	86	83	3	EFO_0008407
Disease	alanine measurement	TNPO1 PFKFB2 CPS1	1.86e-03	86	83	3	EFO_0009765
Disease	aspartate measurement	TTLL12 CPS1	2.07e-03	24	83	2	EFO_0010462
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	HLA-A HLA-B NHLRC2 CPS1 CSGALNACT1	2.15e-03	321	83	5	EFO_0004612, EFO_0004639
Disease	ankylosing spondylitis	FASN HLA-B CAPSL	2.18e-03	91	83	3	EFO_0003898
Disease	TEMPS-A questionnaire	DYNC2H1 ADGRB3	2.25e-03	25	83	2	EFO_0004783
Disease	primary aldosteronism	ADGRB3 CASZ1	2.43e-03	26	83	2	MONDO_0001422
Disease	chronic obstructive pulmonary disease (is_marker_for)	ABCC1 MAPK8 HSPA4	2.62e-03	97	83	3	DOID:3083 (is_marker_for)
Disease	parental longevity	HLA-A HLA-B HLA-C NCAM2 CPS1 RYR3	2.72e-03	494	83	6	EFO_0007796
Disease	triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement	HLA-B HLA-C NHLRC2 CSGALNACT1	2.76e-03	206	83	4	EFO_0004612, EFO_0020947
Disease	response to antineoplastic agent	CACNA2D1 UBR4 RYR2	2.77e-03	99	83	3	GO_0097327

Protein segments in the cluster

Peptide	Gene	Start	Entry
QTAEALGVPYEQWKA	PFKFB1	311	P16118
VPYEQWKILNEIDAG	PFKFB2	316	O60825
LDTGQYQEPWQYVDD	EP300	1106	Q09472
KEQQEGVPNSDEGYW	AMER2	511	Q8N7J2
ATYLPEVAKEQDWDQ	AMMECR1L	231	Q6DCA0
PTGKEGYQAVLQEWE	CSGALNACT1	51	Q8TDX6
ENKEKWEDAQQIYPG	ADGRB3	656	O60242
AVIEKWVNGEYSEEP	CASZ1	86	Q86V15
GYWGEPQKTEEAVDQ	ACSF2	471	Q96CM8
EQEWDPEKPNAYAGI	CAPN5	106	O15484
SESEQYQWDGNLKPQ	DNHD1	3516	Q96M86
IKWSNIYEDNGDDAP	C1orf52	126	Q8N6N3
QDGQRYNDKDVWKPE	COL2A1	36	P02458
YVYQWPAEKENNTGV	ENTPD3	71	O75355
GWKQVEDATPVINYD	RCAN1	171	P53805
KWVSDVDEYAPEGVQ	RAB15	101	P59190
AWYKNTVIPLQQGEE	FANCI	676	Q9NVI1
ENWLYEDGEDQPKQV	HSPA4	656	P34932
EGLIFNWKQDYVDAP	MTMR14	266	Q8NCE2
YTEAKKVPWFDQQNG	H1-10	71	Q92522
VEQEGPEYWDRETQK	HLA-C	76	P10321
YTKVDPDQWNQETGE	IL1RAPL1	411	Q9NZN1
PGRDYIDQWNKVIEQ	MAPK8	226	P45983
VPYEQWKVLNEIDAG	PFKFB4	316	Q16877
NGKDWEYIQDPRTQQ	NRP2	531	O60462
NYGPEVWEDIKKEAQ	GUCY1B1	16	Q02153
IEQEGPEYWDRNTQI	HLA-B	76	P01889
YLQKVDGWEQDLSVP	NHLRC2	41	Q8NBF2
KTVENNPQDFTGWVY	PRPF39	86	Q86UA1
EQWDQPEIYGKVRQE	HFM1	1236	A2PYH4
YQEEEWPQGFGQLTK	ACP2	56	P11117
SQITWDNPKELEGYI	DYNC2H1	661	Q8NCM8
QWLQEEKVPAIYGVD	CPS1	151	P31327
GWVEQDPKEILQSVY	GK2	51	Q14410
PKYQNGEWSEEQVFR	CAPSL	146	Q8WWF8
TRVYPKEAGENWQEN	CACNA2D1	741	P54289
KEAGENWQENPETYE	CACNA2D1	746	P54289
DEYNTNLEGWNEVPD	CDC7	526	O00311
EEAKGVQQYVPEEWA	GPR37L1	51	O60883
VNPDQVEADIGNYWR	DNAH7	791	Q8WXX0
QQLIEWVKDTYSPDE	GCNT3	316	O95395
YWIDPNQGSVEDAIK	COL5A2	1311	P05997
TEVDYSNKQGEEQPW	CAPRIN2	376	Q6IMN6
SNKQGEEQPWEADYA	CAPRIN2	381	Q6IMN6
IEQEGPEYWDQETRN	HLA-A	76	P04439
EQEEPTYFAIWGDNK	DAGLA	621	Q9Y4D2
DPFNVYIESDAWQEK	KCNE1	76	P15382
AVEWESNGQPENNYK	IGHG1	261	P01857
WGSDYSKLQEVEVPE	EML2	321	O95834
LEVNGIWPKYSDIND	EML5	506	Q05BV3
KYPEAQTENQEIGWD	FAM183BP	81	Q6ZVS7
NLVVSGKVYQWDDPD	FASN	951	P49327
EQEWDPQKTEKYAGI	CAPN6	106	Q9Y6Q1
IWEQLSPDIKQQYGE	DHRS9	226	Q9BPW9
SNGSLEEWYDQDKPE	SLC20A1	496	Q8WUM9
YITEQPSEDDIKGQW	RYR2	4616	Q92736
QNGVNPDWEKKVIEY	MCMBP	21	Q9BTE3
EYSETEKEAPWQIQE	ABCC1	1266	P33527
EEVVKPWASGENVYS	RTP3	186	Q9BQQ7
GLEYQEANQVDWELP	PRUNE2	1176	Q8WUY3
KYPETQTENQEVGWD	FAM183A	81	A6NL82
PEDTKNYSGFWNEVD	PKDREJ	1831	Q9NTG1
ERGWYVSVQQPEEAE	SLC38A6	11	Q8IZM9
QDQNDTGEYTWKPVG	PLA2R1	581	Q13018
QNDDYETWLNGKPVV	PLA2R1	1026	Q13018
KVDVYSPGDNQAQDW	AKAP3	16	O75969
EVWPEVESLQDYKNT	CDK1	226	P06493
DETWQQLAEDTYPQK	RIN2	841	Q8WYP3
DQYWEEILLPKNGEN	ZNF343	11	Q6P1L6
EEKFNVDGWTVYNPV	MTM1	156	Q13496
IDWYNPQGEKIISTQ	NCAM2	51	O15394
YITEQPSEDDIKGQW	RYR3	4521	Q15413
GWDTLNYVTEEIKNP	SLC7A7	241	Q9UM01
PTESVQYEDVDGNWI	YY2	36	O15391
SNPYGEWQEIKQEVE	WBP4	291	O75554
QQQPEEYKDWSSGSA	TCF20	1091	Q9UGU0
EKQYPEFPWTDVQAE	TTLL12	536	Q14166
YEWKPDEQGLQQILQ	TNPO1	11	Q92973
GYDSDPVKAWKEAQQ	TOP2A	1081	P11388
IWEEQNTEDQYKNPR	ZNF563	46	Q8TA94
QELYSQQDEEQPQGW	VPS13B	331	Q7Z7G8
EGQSEPFVQKLWEQY	TSNAXIP1	546	Q2TAA8
LEYWKSQQNDEEPVA	UBR4	3106	Q5T4S7
PQSGEWYKFNDEDIE	USP48	361	Q86UV5
EEGEIPWLQYNEVNE	PJA2	496	O43164
VYGEWVPVEKNGEEN	SON	2191	P18583
PEWQDYDQEIKQLQI	UGGT1	1511	Q9NYU2
EEPGEQWNKIYSVET	nan	21	Q8N9L7
AEQEEYVQEGIRWTP	MYO1F	421	O00160
YLEEPEKTQWNNVEN	NECTIN3	486	Q9NQS3